Upcoming webinar features clinical trial thought leaders

We're putting the final pieces together for our upcoming webinar on clinical trial efficiency. Next Tuesday, on December 15, FierceBiotech will host a webinar featuring several outstanding thought leaders offering some new ideas for finding the shortest, most efficient path to proof-of-concept data. We'll be focusing primarily on biotech's sweet spot, that early-stage Phase I and Phase II work that can deliver the kind of data needed to draw in a pharma partner.

Our panel features Neil Bodick, the COO of start-up Flexion and the scientific leader who set up Eli Lilly's Chorus, which helped pioneer a more efficient approach to early-stage research. Ken Getz, Senior Research Fellow, Tufts Center for the Study of Drug Development, will cover some of his new work in the field. And they'll be joined by Barbara Tardiff, Corporate Vice President of Data Sciences at Parexel and Royce Morrison, M.D., MSEE, Director of Clinical Strategy for Charles River Clinical Services.

This promises to be one of our best webinars of the year. If you're engaged in early-stage trials, you won't want to miss it. Click here to register. - John Carroll

Suggested Articles

Bristol Myers Squibb is teaming up with Repare Therapeutics to find new synthetic lethality targets in a deal that could be worth billions.

Biotech Orpheris has been given the FDA go-ahead for a phase 2 aimed at calming the cytokine storm sometimes caused by COVID-19.

PureTech plans to start a trial in the emerging population of patients who survive COVID-19 only to suffer lasting damage in the third quarter.